Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant …

N Han, H Yun, J Hong, IW Kim, E Ji, SH Hong… - European journal of …, 2013 - Springer
Purpose Tacrolimus is a commonly used immunosuppressant in solid organ transplantation
recipients, but it is characterized by a narrow therapeutic range and large inter-individual …

Population pharmacokinetic–pharmacogenetic model of tacrolimus in the early period after kidney transplantation

N Han, S Ha, H Yun, MG Kim, SI Min… - Basic & clinical …, 2014 - Wiley Online Library
As tacrolimus has a rather narrow therapeutic range and high individual variability in its
pharmacokinetics, it is important to determine the cause of the variation in tacrolimus …

Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis

…, H Yun, ES Kim, YJ Lee, YJ Cho, HI Yoon… - International journal of …, 2017 - Elsevier
Control of multi-drug-resistant tuberculosis (MDR-TB) requires extensive, supervised
chemotherapy because second-line anti-TB drugs have a narrower therapeutic range than first-line …

Effects of type 2 diabetes mellitus on the population pharmacokinetics of rifampin in tuberculosis patients

…, JI Lee, HD Choi, J Kim, JS Park, YJ Cho, HI Yoon… - Tuberculosis, 2015 - Elsevier
Diabetes mellitus (DM) is a well-known risk factor to develop tuberculosis (TB). Some reports
indicate the serum concentrations of anti-TB drugs are lower in patients with TB and DM …

External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients

JJ Mao, Z Jiao, HY Yun, CY Zhao… - British journal of …, 2018 - Wiley Online Library
Aims Several population pharmacokinetic (popPK) models for ciclosporin (CsA) in adult renal
transplant recipients have been constructed to optimize the therapeutic regimen of CsA. …

[HTML][HTML] Fine-tuning of BERT model to accurately predict drug–target interactions

H Kang, S Goo, H Lee, JW Chae, HY Yun, S Jung - Pharmaceutics, 2022 - mdpi.com
The identification of optimal drug candidates is very important in drug discovery. Researchers
in biology and computational sciences have sought to use machine learning (ML) to …

[HTML][HTML] Increased exposure of tacrolimus by co-administered mycophenolate mofetil: population pharmacokinetic analysis in healthy volunteers

JH Kim, N Han, MG Kim, HY Yun, S Lee, E Bae… - Scientific Reports, 2018 - nature.com
The objective of the study was to investigate the pharmacokinetic drug-drug interactions
between tacrolimus (TAC) and mycophenolate mofetil (MMF) in healthy Korean male volunteers…

Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays

…, X Zang, L Kagan, TH Kim, MG Kim, H Yun… - European Journal of …, 2017 - Elsevier
In this study, Caco-2 permeability results from different laboratories were compared. Six
different sets of apparent permeability coefficient (P app ) values reported in the literature were …

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of …

…, S Jung, JY Lee, JH Lee, H Yun… - CPT …, 2022 - Wiley Online Library
… Lien Thi Ngo, Sung-yoon Yang and Sooyoung Shin contributed equally to this work as the
first-authors. Jong-Hwa Lee, Hwi-yeol Yun and Jung-woo Chae contributed equally to this …

Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients

N Han, H Yun, IW Kim, YJ Oh, YS Kim… - European journal of clinical …, 2014 - Springer
Purpose Enteric-coated mycophenolate sodium (EC-MPS) is effective and safe in
preventing rejection after transplantation and is mainly transported by ABCs and OATPs and …